Modulation of hsv infection

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2554203

Toll-like receptor 2 (TLR2) has been found to mediate certain effects of HSV infection, particularly in neonates. Compounds that decrease TLR2 expression or activity are useful for ameliorating such deleterious effects.

On a découvert que le récepteur TLR2 joue un rôle dans certains effets de l'infection par HSV, en particulier, chez les nouveau-nés. Des composés diminuant l'expression ou l'activité de TLR2 sont utiles pour améliorer ces effets délétères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modulation of hsv infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of hsv infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of hsv infection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1766857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.